Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 1278
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT03478397 | Evaluation of a mHealth Intervention to Increase Adherence to Triage of Self-collected HPV+ Women (ATICA Project) | ||
| NCT01516216 | Study of Vitamin D in Untreated Metastatic Colorectal Cancer | ||
| NCT05501704 | ETHAN - ET for Male BC | ||
| NCT00973440 | Computer-Based Comprehensive Geriatric Assessment in Oncology for Individuals 70 or Older With Gastrointestinal Malignancies | ||
| NCT01579552 | Promoting Breast Cancer Screening in Women Who Survived Childhood Cancer | ||
| NCT06369155 | Azenosertib in Uterine Serous Carcinoma: Biomarker Study | ||
| NCT03075527 | A Phase 2 Study of Durvalumab in Combination With Tremelimumab in Malignant Pleural Mesothelioma | ||
| NCT01484314 | Eltrombopag for Thrombocytopenia in Patients With Relapsed Multiple Myeloma | ||
| NCT00181558 | Atrasentan and Zometa for Men With Prostate Cancer Metastatic to Bone | ||
| NCT00142168 | CC-5013 (Lenalidomide) and Rituximab in Waldenstrom's Macroglobulinemia | ||
| NCT04950608 | Pilot Study of Psilocybin-Assisted Therapy for Demoralization in Patients Receiving Hospice Care | ||
| NCT02770014 | Rapid Plasma Genotyping For Early Initiation Of Erlotinib In EGFR Mutant Lung Cancer | ||
| NCT06964009 | DT2216 + Paclitaxel in Platinum-Resistant Ovarian Cancer | ||
| NCT01402687 | SNP-Based Prediction of Oral Mucositis Risk in Patients Receiving Hematopoietic Stem Cell Transplants (HSCT) | ||
| NCT00215514 | Adjuvant Chemoradiation Therapy for Gastric or Gastroesophageal Junction Adenocarcinoma | ||
| NCT04323774 | Intervention For AYAS With Cancer Risk Syndromes | ||
| NCT05212025 | Adavosertib and Gemcitabine in Advanced Pancreatic | ||
| NCT04421560 | Pembrolizumab, Ibrutinib and Rituximab in PCNSL | ||
| NCT06317220 | Vedolizumab for the Treatment of Collagenous Gastritis | ||
| NCT03408314 | The PediQUEST Response Intervention Study | ||
| NCT06518551 | Elotuzumab + Iberdomide + Dexamethasone Post Ide-Cel in RRMM | ||
| NCT00441142 | Zactima With Temodar During Radiation Treatment for Newly Diagnosed Stage IV Brain Tumors | ||
| NCT06015659 | ZN-c3 + Gemcitabine in Pancreatic Cancer | ||
| NCT00020618 | Inhaled Morphine Compared With Morphine By Mouth in Treating Cancer Patients With Breakthrough Pain | ||
| NCT00827359 | Biomarker Trial of Everolimus in Patients With Advanced Renal Cell Carcinoma | ||
| NCT00459069 | The Use of Dendritic Cell/Tumor Fusions as a Novel Tumor Vaccine in Patients With Multiple Myeloma | ||
| NCT00852462 | Lung Cancer Symptom Assessment and Management Intervention | ||
| NCT00487305 | Vaccination for the Treatment of Previously Untreated or Relapsed Follicular Lymphoma | ||
| NCT01065662 | AZD2171 and Temsirolimus in Patients With Advanced Gynecological Malignancies | ||
| NCT00005988 | Bone Marrow Transplantation With Specially Treated Bone Marrow in Treating Patients With Hematologic Cancer That Have Not Responded to Previous Therapy | ||
| NCT05176288 | Avelumab, Palbociclib and Axitinib in Advanced RCC | ||
| NCT02439138 | Study of Phosphatidylinositol-3-kinase (PI3K) Inhibitor Idelalisib (GS-1101) in Waldenström Macroglobulinemia | ||
| NCT00776594 | Androgen Deprivation Therapy +/- Bevacizumab for PSA Recurrence of Prostate Cancer After Definitive Local Therapy | ||
| NCT00874562 | Rapamycin in Relapsed Acute Lymphoblastic Leukemia | ||
| NCT06055296 | Multisite Implementation of COMPRENDO | ||
| NCT07148180 | A Multi-Site Break Through Cancer Trial: Targeting Measurable Residual Disease in Patients With Acute Myeloid Leukemia: A Phase 1/2 Study of Tagraxofusp, Azacitidine, and Venetoclax | ||
| NCT00821080 | Vandetanib and Sirolimus in Patients With Recurrent Glioblastoma | ||
| NCT01154920 | Paclitaxel, Carboplatin and Cetuximab (PCC) With Cetuximab, Docetaxel, Cisplatin and Fluorouracil (C-TPF) in Previously Untreated Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma | ||
| NCT01750762 | Lenalidomide After Allo Transplant | ||
| NCT05706766 | Prehabilitation Exercise Training in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation | ||
| NCT01834183 | Tivozanib + Gemcitabine in Metastatic RCC | ||
| NCT02123966 | An Open Label Phase II Trial of Topical Sirolimus for the Treatment of Refractory Oral Chronic Graft-versus-Host-Disease | ||
| NCT00911820 | Cisplatin, Irinotecan and Bevacizumab (PCA) Versus Docetaxel, Cisplatin, Irinotecan and Bevacizumab (TPCA) in Metastatic Esophageal and Gastric Cancer | ||
| NCT00139269 | Study of Docetaxel in Combination With Cisplatin and 5-Fluorouracil in Locally Advanced Squamous Cell Carcinoma of the Head and Neck | ||
| NCT00908960 | Enoxaparin Thromboprophylaxis in Cancer Patients With Elevated Tissue Factor Bearing Microparticles | ||
| NCT05796570 | A Pilot Study to Evaluate the Feasibility of Post-Hematopoietic Stem Cell Transplant Prophylaxis With Decitabine Combined With Filgrastim for Children and Young Adults With AML, MDS and Related Myeloid Malignancies | ||
| NCT02978443 | A Biomarker Study in Advanced Mucosal or Acral Lentiginous Melanoma Receiving Nivolumab in Combination With Ipilimumab | ||
| NCT00459043 | Docetaxel in Combination With Zactima (ZD6474) in Patients With Locally Advanced Squamous Cell Carcinoma of the the Head and Neck | ||
| NCT00330252 | Weekly Subcutaneous Alemtuzumab and Rituximab for Relapsed CLL | ||
| NCT00148720 | Capecitabine in Women With Operable Breast Cancer |
